Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo.
about
Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia BThe interplay of post-translational modification and gene therapyDevelopments in the treatment of hemophilia B: focus on emerging gene therapyInduced pluripotent stem cells in hematology: current and future applicationsGene therapy for hemophiliaGene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Development of Gene Transfer for Induction of Antigen-specific Tolerance.Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene TransferMultiple sclerosis: getting personal with induced pluripotent stem cells.Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease.Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy.IL12-mediated liver inflammation reduces the formation of AAV transcriptionally active forms but has no effect over preexisting AAV transgene expression.Immune responses to AAV vectors: overcoming barriers to successful gene therapyCartilage tissue engineering: recent advances and perspectives from gene regulation/therapy.Global Screening of Antiviral Genes that Suppress Baculovirus Transgene Expression in Mammalian Cells.Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors.Recent advances in oncolytic adenovirus therapies for cancer.Progress towards generation of human haematopoietic stem cells.A view of human haematopoietic development from the Petri dish.In Vivo Hematopoietic Stem Cell Transduction.One microRNA controls both angiogenesis and TLR-mediated innate immunity to nucleic acids.Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer.Current and Future Treatments for Lysosomal Storage Disorders.Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy.
P2860
Q21245486-B8B80F2C-0A69-4EC7-A957-D1D5392D172FQ26751281-833BC2E9-3191-42B2-952C-323CDC81F15AQ26823376-84349862-30BD-436B-899E-15BD9D8A461EQ27016090-35B346E9-0B95-42BF-B088-10206E100A27Q28081911-6C2D290A-FBA8-4B15-9516-70CAE759AD87Q33881920-CE2C5EEF-A921-4FE0-95F4-A7D53AEF8784Q34794525-0D2650AC-5EAE-41AE-B078-685D51FA0C80Q35561776-5C54C118-FF76-4A02-9F86-DFB47FCD6E03Q36293848-4E9E3F77-61F2-41AE-96DD-900B957409FEQ36543422-4347F166-6799-4C91-8358-245D1E060223Q36664224-09B36BE3-32EE-45FB-8E30-EE353E024624Q36976498-80B10B28-363D-4C2F-9E91-3433DE2B7D86Q36983740-C9BBDF07-9F13-4AFC-8B4C-135984845142Q38345989-60D5B9C3-951F-4B80-B558-302D1E636B33Q38694359-4F1EB125-0999-4732-81BE-D43FFB18858DQ38714964-BF5783A2-A118-420C-9B58-EFB32604A2D7Q38886593-2528ACD3-4921-4A3A-BC90-6BC3980A25E2Q38977109-A9BD82AF-F8E3-4E31-BB63-5F860596156EQ39017189-164E1344-06C2-47D2-AC2A-CC10EE76F990Q40045829-36E34F1C-C108-4C8C-BFE8-E7A169D43018Q41922823-C601CC50-70E6-48AF-978B-8244B242B300Q41925180-2E381445-9844-4F6C-B9E6-970493EAC7C3Q45873942-CDF4E879-4A76-493E-B2C3-2D9DFAB8B04AQ51847569-E5C75C99-29B9-47B8-91C6-78631199C919
P2860
Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Differential type I interferon ...... ociated viral vectors in vivo.
@ast
Differential type I interferon ...... ociated viral vectors in vivo.
@en
type
label
Differential type I interferon ...... ociated viral vectors in vivo.
@ast
Differential type I interferon ...... ociated viral vectors in vivo.
@en
prefLabel
Differential type I interferon ...... ociated viral vectors in vivo.
@ast
Differential type I interferon ...... ociated viral vectors in vivo.
@en
P2093
P2860
P356
P1433
P1476
Differential type I interferon ...... ociated viral vectors in vivo.
@en
P2093
Brendan Lee
Donna J Palmer
Geoffrey L Rogers
Irene Zolotukhin
Masataka Suzuki
Racel G Cela
Roland W Herzog
Terry K Bertin
P2860
P304
P356
10.1038/MT.2012.277
P577
2013-01-15T00:00:00Z